Third Rock Ventures Ii, L.P. is > 10% Shareholder of Revolution Medicines, Inc.. Currently has a direct ownership of 0 shares of RVMD, which is worth approximately $0. The most recent transaction as insider was on Jun 04, 2021, when has been sold 164,996 shares (Common Stock) at a price of $30.23 per share, resulting in proceeds of $4,987,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Third Rock Ventures II, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2021
SELL
Open market or private sale
$4,987,829 $30.23 p/Share
164,996 Reduced 100.0%
0 Common Stock
Jun 03 2021
SELL
Open market or private sale
$11,419,134 $30.2 p/Share
378,117 Reduced 69.62%
164,996 Common Stock
May 26 2021
SELL
Open market or private sale
$37,588,659 $30.53 p/Share
1,231,204 Reduced 69.39%
543,113 Common Stock
May 25 2021
SELL
Open market or private sale
$4,175,550 $30.93 p/Share
135,000 Reduced 7.07%
1,774,317 Common Stock

Also insider at

MYOK
MyoKardia Inc
ALNA
Allena Pharmaceuticals, Inc. Healthcare
JNCE
Jounce Therapeutics, Inc. Healthcare
TRV

Third Rock Ventures Ii, L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on RVMD

Follow Revolution Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD